However, in breast cancer (Artibani et al., 2017), the WT1 gene is highly and specifically expressed, indicating that the known association between WT1 expression in breast cancer and poor prognosis is potentially due to poor chemotherapy response, so the WT1 gene can also be considered a proto-oncogene, which is similar to the results of our study. Here, WT1 is linked to breast carcinoma.